Drug interactions for the following drug(s)
Applies to: pramipexole dihydrochloride 1.5 MG 24HR Extended Release Oral Tablet <> gabapentin 300 MG Oral Capsule
Gabapentin enacarbil may increase the sedative activities of Pramipexole.
Applies to: Carbidopa 25 MG / Levodopa 100 MG Extended Release Oral Tablet <> Primidone 50 MG Oral Tablet
The risk or severity of adverse effects can be increased when Primidone is combined with Levodopa.
Applies to: Primidone 50 MG Oral Tablet <> pramipexole dihydrochloride 1.5 MG 24HR Extended Release Oral Tablet
Primidone may increase the sedative activities of Pramipexole.
Applies to: Carisoprodol 350 MG Oral Tablet <> Carbidopa 25 MG / Levodopa 100 MG Extended Release Oral Tablet
The risk or severity of adverse effects can be increased when Carisoprodol is combined with Levodopa.
Applies to: gabapentin 300 MG Oral Capsule <> Divalproex Sodium 250 MG Delayed Release Oral Tablet
The risk or severity of adverse effects can be increased when Valproic acid is combined with Gabapentin.
Applies to: Bisacodyl 5 MG Delayed Release Oral Tablet <> Primidone 50 MG Oral Tablet
The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Primidone.
Applies to: Carbidopa 25 MG / Levodopa 100 MG Extended Release Oral Tablet <> gabapentin 300 MG Oral Capsule
The risk or severity of adverse effects can be increased when Gabapentin is combined with Levodopa.
Applies to: gabapentin 300 MG Oral Capsule <> pramipexole dihydrochloride 1.5 MG 24HR Extended Release Oral Tablet
Gabapentin may increase the sedative activities of Pramipexole.
Applies to: Carbidopa 25 MG / Levodopa 100 MG Extended Release Oral Tablet <> Divalproex Sodium 250 MG Delayed Release Oral Tablet
The risk or severity of adverse effects can be increased when Valproic acid is combined with Levodopa.
Applies to: Carbidopa 25 MG / Levodopa 100 MG Extended Release Oral Tablet <> pramipexole dihydrochloride 1.5 MG 24HR Extended Release Oral Tablet
Carbidopa may decrease the excretion rate of Pramipexole which could result in a higher serum level.
Applies to: gabapentin 300 MG Oral Capsule <> gabapentin 300 MG Oral Capsule
The risk or severity of adverse effects can be increased when Gabapentin is combined with Gabapentin enacarbil.
Applies to: Divalproex Sodium 250 MG Delayed Release Oral Tablet <> pramipexole dihydrochloride 1.5 MG 24HR Extended Release Oral Tablet
Valproic acid may increase the sedative activities of Pramipexole.
Applies to: Carisoprodol 350 MG Oral Tablet <> gabapentin 300 MG Oral Capsule
The risk or severity of adverse effects can be increased when Carisoprodol is combined with Gabapentin.
Applies to: UNITHROID 88 MCG Oral Tablet <> Divalproex Sodium 250 MG Delayed Release Oral Tablet
The metabolism of Levothyroxine can be decreased when combined with Valproic acid.
Applies to: Carisoprodol 350 MG Oral Tablet <> Divalproex Sodium 250 MG Delayed Release Oral Tablet
The risk or severity of adverse effects can be increased when Carisoprodol is combined with Valproic acid.
Applies to: Primidone 50 MG Oral Tablet <> gabapentin 300 MG Oral Capsule
The risk or severity of adverse effects can be increased when Primidone is combined with Gabapentin.
Applies to: pramipexole dihydrochloride 1.5 MG 24HR Extended Release Oral Tablet <> Carbidopa 25 MG / Levodopa 100 MG Extended Release Oral Tablet
Carbidopa may decrease the excretion rate of Pramipexole which could result in a higher serum level.
Applies to: Primidone 50 MG Oral Tablet <> UNITHROID 88 MCG Oral Tablet
The metabolism of Levothyroxine can be increased when combined with Primidone.
Applies to: Carisoprodol 350 MG Oral Tablet <> pramipexole dihydrochloride 1.5 MG 24HR Extended Release Oral Tablet
Carisoprodol may increase the sedative activities of Pramipexole.
Applies to: Carisoprodol 350 MG Oral Tablet <> Primidone 50 MG Oral Tablet
The risk or severity of adverse effects can be increased when Carisoprodol is combined with Primidone.
Applies to: Divalproex Sodium 250 MG Delayed Release Oral Tablet <> gabapentin 300 MG Oral Capsule
The risk or severity of adverse effects can be increased when Valproic acid is combined with Gabapentin enacarbil.
Applies to: gabapentin 300 MG Oral Capsule <> Carbidopa 25 MG / Levodopa 100 MG Extended Release Oral Tablet
Carbidopa may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.
Applies to: Primidone 50 MG Oral Tablet <> Divalproex Sodium 250 MG Delayed Release Oral Tablet
The serum concentration of Phenobarbital, an active metabolite of Primidone, can be increased when used in combination with Valproic acid.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
Applies to: pramipexole dihydrochloride 1.5 MG 24HR Extended Release Oral Tablet <> gabapentin 300 MG Oral Capsule
Drug1 (rxcui = 901550, name = 24 HR pramipexole dihydrochloride 1.5 MG Extended Release Oral Tablet, tty = SCD). Drug2 (rxcui = 310431, name = gabapentin 300 MG Oral Capsule, tty = SCD). Drug1 is resolved to pramipexole, Drug2 is resolved to gabapentin enacarbil and interaction asserted in DrugBank between Pramipexole and Gabapentin enacarbil.
Applies to: Carbidopa 25 MG / Levodopa 100 MG Extended Release Oral Tablet <> Primidone 50 MG Oral Tablet
Drug1 (rxcui = 308988, name = carbidopa 25 MG / levodopa 100 MG Extended Release Oral Tablet, tty = SCD). Drug2 (rxcui = 198150, name = primidone 50 MG Oral Tablet, tty = SCD). Drug1 is resolved to levodopa, Drug2 is resolved to primidone and interaction asserted in DrugBank between Levodopa and Primidone.
Applies to: Primidone 50 MG Oral Tablet <> pramipexole dihydrochloride 1.5 MG 24HR Extended Release Oral Tablet
Drug1 (rxcui = 198150, name = primidone 50 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 901550, name = 24 HR pramipexole dihydrochloride 1.5 MG Extended Release Oral Tablet, tty = SCD). Drug1 is resolved to primidone, Drug2 is resolved to pramipexole and interaction asserted in DrugBank between Primidone and Pramipexole.
Applies to: Carisoprodol 350 MG Oral Tablet <> Carbidopa 25 MG / Levodopa 100 MG Extended Release Oral Tablet
Drug1 (rxcui = 197446, name = carisoprodol 350 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 308988, name = carbidopa 25 MG / levodopa 100 MG Extended Release Oral Tablet, tty = SCD). Drug1 is resolved to carisoprodol, Drug2 is resolved to levodopa and interaction asserted in DrugBank between Carisoprodol and Levodopa.
Applies to: gabapentin 300 MG Oral Capsule <> Divalproex Sodium 250 MG Delayed Release Oral Tablet
Drug1 (rxcui = 310431, name = gabapentin 300 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 1099678, name = divalproex sodium 250 MG Delayed Release Oral Tablet, tty = SCD). Drug1 is resolved to gabapentin, Drug2 is resolved to valproate and interaction asserted in DrugBank between Gabapentin and Valproic acid.
Applies to: Bisacodyl 5 MG Delayed Release Oral Tablet <> Primidone 50 MG Oral Tablet
Drug1 (rxcui = 308753, name = bisacodyl 5 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 198150, name = primidone 50 MG Oral Tablet, tty = SCD). Drug1 is resolved to bisacodyl, Drug2 is resolved to primidone and interaction asserted in DrugBank between Bisacodyl and Primidone.
Applies to: Carbidopa 25 MG / Levodopa 100 MG Extended Release Oral Tablet <> gabapentin 300 MG Oral Capsule
Drug1 (rxcui = 308988, name = carbidopa 25 MG / levodopa 100 MG Extended Release Oral Tablet, tty = SCD). Drug2 (rxcui = 310431, name = gabapentin 300 MG Oral Capsule, tty = SCD). Drug1 is resolved to levodopa, Drug2 is resolved to gabapentin and interaction asserted in DrugBank between Levodopa and Gabapentin. Drug1 is resolved to levodopa, Drug2 is resolved to gabapentin enacarbil and interaction asserted in DrugBank between Levodopa and Gabapentin enacarbil. Drug1 is resolved to carbidopa, Drug2 is resolved to gabapentin enacarbil and interaction asserted in DrugBank between Carbidopa and Gabapentin enacarbil.
Applies to: gabapentin 300 MG Oral Capsule <> pramipexole dihydrochloride 1.5 MG 24HR Extended Release Oral Tablet
Drug1 (rxcui = 310431, name = gabapentin 300 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 901550, name = 24 HR pramipexole dihydrochloride 1.5 MG Extended Release Oral Tablet, tty = SCD). Drug1 is resolved to gabapentin, Drug2 is resolved to pramipexole and interaction asserted in DrugBank between Gabapentin and Pramipexole.
Applies to: Carbidopa 25 MG / Levodopa 100 MG Extended Release Oral Tablet <> Divalproex Sodium 250 MG Delayed Release Oral Tablet
Drug1 (rxcui = 308988, name = carbidopa 25 MG / levodopa 100 MG Extended Release Oral Tablet, tty = SCD). Drug2 (rxcui = 1099678, name = divalproex sodium 250 MG Delayed Release Oral Tablet, tty = SCD). Drug1 is resolved to levodopa, Drug2 is resolved to valproic acid and interaction asserted in DrugBank between Levodopa and Valproic acid. Drug1 is resolved to levodopa, Drug2 is resolved to valproate and interaction asserted in DrugBank between Levodopa and Valproic acid.
Applies to: Carbidopa 25 MG / Levodopa 100 MG Extended Release Oral Tablet <> pramipexole dihydrochloride 1.5 MG 24HR Extended Release Oral Tablet
Drug1 (rxcui = 308988, name = carbidopa 25 MG / levodopa 100 MG Extended Release Oral Tablet, tty = SCD). Drug2 (rxcui = 901550, name = 24 HR pramipexole dihydrochloride 1.5 MG Extended Release Oral Tablet, tty = SCD). Drug1 is resolved to carbidopa, Drug2 is resolved to pramipexole and interaction asserted in DrugBank between Carbidopa and Pramipexole. Drug1 is resolved to levodopa, Drug2 is resolved to pramipexole and interaction asserted in DrugBank between Levodopa and Pramipexole.
Applies to: gabapentin 300 MG Oral Capsule <> gabapentin 300 MG Oral Capsule
Drug1 (rxcui = 310431, name = gabapentin 300 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 310431, name = gabapentin 300 MG Oral Capsule, tty = SCD). Drug1 is resolved to gabapentin, Drug2 is resolved to gabapentin enacarbil and interaction asserted in DrugBank between Gabapentin and Gabapentin enacarbil. Drug1 is resolved to gabapentin enacarbil, Drug2 is resolved to gabapentin and interaction asserted in DrugBank between Gabapentin enacarbil and Gabapentin.
Applies to: Divalproex Sodium 250 MG Delayed Release Oral Tablet <> pramipexole dihydrochloride 1.5 MG 24HR Extended Release Oral Tablet
Drug1 (rxcui = 1099678, name = divalproex sodium 250 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 901550, name = 24 HR pramipexole dihydrochloride 1.5 MG Extended Release Oral Tablet, tty = SCD). Drug1 is resolved to valproate, Drug2 is resolved to pramipexole and interaction asserted in DrugBank between Valproic acid and Pramipexole. Drug1 is resolved to valproic acid, Drug2 is resolved to pramipexole and interaction asserted in DrugBank between Valproic acid and Pramipexole.
Applies to: Carisoprodol 350 MG Oral Tablet <> gabapentin 300 MG Oral Capsule
Drug1 (rxcui = 197446, name = carisoprodol 350 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 310431, name = gabapentin 300 MG Oral Capsule, tty = SCD). Drug1 is resolved to carisoprodol, Drug2 is resolved to gabapentin and interaction asserted in DrugBank between Carisoprodol and Gabapentin. Drug1 is resolved to carisoprodol, Drug2 is resolved to gabapentin enacarbil and interaction asserted in DrugBank between Carisoprodol and Gabapentin enacarbil.
Applies to: UNITHROID 88 MCG Oral Tablet <> Divalproex Sodium 250 MG Delayed Release Oral Tablet
Drug1 (rxcui = 966232, name = levothyroxine sodium 0.088 MG Oral Tablet [Unithroid], tty = SBD). Drug2 (rxcui = 1099678, name = divalproex sodium 250 MG Delayed Release Oral Tablet, tty = SCD). Drug1 is resolved to levothyroxine, Drug2 is resolved to valproate and interaction asserted in DrugBank between Levothyroxine and Valproic acid. Drug1 is resolved to levothyroxine, Drug2 is resolved to valproic acid and interaction asserted in DrugBank between Levothyroxine and Valproic acid.
Applies to: Carisoprodol 350 MG Oral Tablet <> Divalproex Sodium 250 MG Delayed Release Oral Tablet
Drug1 (rxcui = 197446, name = carisoprodol 350 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1099678, name = divalproex sodium 250 MG Delayed Release Oral Tablet, tty = SCD). Drug1 is resolved to carisoprodol, Drug2 is resolved to valproic acid and interaction asserted in DrugBank between Carisoprodol and Valproic acid. Drug1 is resolved to carisoprodol, Drug2 is resolved to valproate and interaction asserted in DrugBank between Carisoprodol and Valproic acid.
Applies to: Primidone 50 MG Oral Tablet <> gabapentin 300 MG Oral Capsule
Drug1 (rxcui = 198150, name = primidone 50 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 310431, name = gabapentin 300 MG Oral Capsule, tty = SCD). Drug1 is resolved to primidone, Drug2 is resolved to gabapentin and interaction asserted in DrugBank between Primidone and Gabapentin. Drug1 is resolved to primidone, Drug2 is resolved to gabapentin enacarbil and interaction asserted in DrugBank between Primidone and Gabapentin enacarbil.
Applies to: pramipexole dihydrochloride 1.5 MG 24HR Extended Release Oral Tablet <> Carbidopa 25 MG / Levodopa 100 MG Extended Release Oral Tablet
Drug1 (rxcui = 901550, name = 24 HR pramipexole dihydrochloride 1.5 MG Extended Release Oral Tablet, tty = SCD). Drug2 (rxcui = 308988, name = carbidopa 25 MG / levodopa 100 MG Extended Release Oral Tablet, tty = SCD). Drug1 is resolved to pramipexole, Drug2 is resolved to carbidopa anhydrous and interaction asserted in DrugBank between Pramipexole and Carbidopa.
Applies to: Primidone 50 MG Oral Tablet <> UNITHROID 88 MCG Oral Tablet
Drug1 (rxcui = 198150, name = primidone 50 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 966232, name = levothyroxine sodium 0.088 MG Oral Tablet [Unithroid], tty = SBD). Drug1 is resolved to primidone, Drug2 is resolved to levothyroxine and interaction asserted in DrugBank between Primidone and Levothyroxine.
Applies to: Carisoprodol 350 MG Oral Tablet <> pramipexole dihydrochloride 1.5 MG 24HR Extended Release Oral Tablet
Drug1 (rxcui = 197446, name = carisoprodol 350 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 901550, name = 24 HR pramipexole dihydrochloride 1.5 MG Extended Release Oral Tablet, tty = SCD). Drug1 is resolved to carisoprodol, Drug2 is resolved to pramipexole and interaction asserted in DrugBank between Carisoprodol and Pramipexole.
Applies to: Carisoprodol 350 MG Oral Tablet <> Primidone 50 MG Oral Tablet
Drug1 (rxcui = 197446, name = carisoprodol 350 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 198150, name = primidone 50 MG Oral Tablet, tty = SCD). Drug1 is resolved to carisoprodol, Drug2 is resolved to primidone and interaction asserted in DrugBank between Carisoprodol and Primidone.
Applies to: Divalproex Sodium 250 MG Delayed Release Oral Tablet <> gabapentin 300 MG Oral Capsule
Drug1 (rxcui = 1099678, name = divalproex sodium 250 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 310431, name = gabapentin 300 MG Oral Capsule, tty = SCD). Drug1 is resolved to valproate, Drug2 is resolved to gabapentin enacarbil and interaction asserted in DrugBank between Valproic acid and Gabapentin enacarbil. Drug1 is resolved to valproic acid, Drug2 is resolved to gabapentin and interaction asserted in DrugBank between Valproic acid and Gabapentin. Drug1 is resolved to valproic acid, Drug2 is resolved to gabapentin enacarbil and interaction asserted in DrugBank between Valproic acid and Gabapentin enacarbil.
Applies to: gabapentin 300 MG Oral Capsule <> Carbidopa 25 MG / Levodopa 100 MG Extended Release Oral Tablet
Drug1 (rxcui = 310431, name = gabapentin 300 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 308988, name = carbidopa 25 MG / levodopa 100 MG Extended Release Oral Tablet, tty = SCD). Drug1 is resolved to gabapentin enacarbil, Drug2 is resolved to carbidopa anhydrous and interaction asserted in DrugBank between Gabapentin enacarbil and Carbidopa.
Applies to: Primidone 50 MG Oral Tablet <> Divalproex Sodium 250 MG Delayed Release Oral Tablet
Drug1 (rxcui = 198150, name = primidone 50 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1099678, name = divalproex sodium 250 MG Delayed Release Oral Tablet, tty = SCD). Drug1 is resolved to primidone, Drug2 is resolved to valproate and interaction asserted in DrugBank between Primidone and Valproic acid. Drug1 is resolved to primidone, Drug2 is resolved to valproic acid and interaction asserted in DrugBank between Primidone and Valproic acid.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.